Disease & disorder
STT3B-congenital disorder of glycosylation
MONDO:0014271
STT3B-CDG is a form of congenital disorders of N-linked glycosylation characterized by intrauterine growth retardation, microcephaly, failure to thrive, developmental delay, intellectual disability, hypotonia, seizures, optic nerve atrophy and respiratory difficulties. Genital abnormalities (micropenis, hypoplastic scrotum, undescended testes) have also been reported. STT3B-CDG is caused by mutations in the gene STT3B (3p24.1).
Outbreak surveillance
Global reported eventsExplore recent public health notices potentially related to STT3B-congenital disorder of glycosylation. Results are keyword matches, not yet verified disease-to-outbreak relationships.
View STT3B-congenital disorder of glycosylation on the outbreak map →Advertisement
Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.